Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission

Clin Case Rep. 2018 Apr 10;6(6):1023-1028. doi: 10.1002/ccr3.1506. eCollection 2018 Jun.

Abstract

Myeloid/natural killer cell precursor acute leukemia (MNKPL) is a rare leukemia subtype characterized by a high incidence of extramedullary infiltration. No appropriate treatment strategy has so far been developed. Acute myelogenous leukemia-type chemotherapy combined with L-Asparaginase is an effective treatment for MNKPL. Hematopoietic cell transplantation is a second option in refractory cases.

Keywords: Hematopoietic cell transplantation; L‐Asparaginase; myeloid/natural killer cell precursor acute leukemia.

Publication types

  • Case Reports